First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: T. A. Yap, D. S. Boss, P. C. Fong, M. Roelvink, A. Tutt, J. Carmichael, M. J. O’Connor, S. B. Kaye, J. H. Schellens, J. S. de Bono
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2259017169